Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

NCT07618299 is registered in ClinicalTrials.gov with Meitheal Pharmaceuticals, Inc. as lead sponsor.

NCT NCT07618299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07618299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women
Lead sponsor
Meitheal Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
September 22, 2026
Completion date
September 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy lactating women